Market Cap 476.30M
Revenue (ttm) 0.00
Net Income (ttm) -167.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 250,600
Avg Vol 463,558
Day's Range N/A - N/A
Shares Out 58.51M
Stochastic %K 54%
Beta -0.05
Analysts Strong Sell
Price Target $32.50

Latest News on CGEM

Cullinan Therapeutics: Casting A Wide Net With Their Pipeline

Jan 8, 2025, 5:26 PM EST - 3 months ago

Cullinan Therapeutics: Casting A Wide Net With Their Pipeline